Not open to the public yet.
If you were given a password, it goes here.
Reduced arousal and lubrication are among the most commonly reported women's health concerns — and among the least often treated. OH! connects you with a licensed clinician who reviews your health history and, if appropriate, prescribes a non-hormonal topical treatment. Delivered in unmarked packaging.
Founding members get first access and a founding rate · Cancel anytime
Physical arousal depends on genital blood flow, nerve response, and tissue sensitivity. All three are affected by hormonal change, common medications, circulation, and sleep. When they decline, the physical response declines with them — regardless of how you feel about your partner or yourself.
the likelihood of desire and arousal difficulty in early perimenopause versus premenopause.
Monash University midlife study ↗report reduced lubrication — among the most common menopause-related symptoms.
Menopause symptom prevalence (NIH PMC) ↗About these figures. Each number describes how common these experiences are among women generally, drawn from peer-reviewed research and established medical references and linked to its source above. None describes what any treatment does, and none is a claim about outcomes from OH! Prevalence estimates vary between studies depending on population and definition. Further reading: StatPearls, Female Sexual Interest & Arousal Disorder · Boston University, Epidemiology of FSD.
Roughly half of women in midlife report a problem.
Most never bring it up. Most doctors never ask.
Monash University midlife study · Sarin et al., PLOS ONE · Boston University School of Public Health
Compounding pharmacies have prepared topical treatments for arousal difficulty for years, and clinicians have prescribed them off-label. There is peer-reviewed literature on them. What there has never been is a company willing to talk about it plainly.
Because it travelled by word of mouth. If your gynecologist happened to know, you could get it. If not, you were told to have a glass of wine and relax. Formulations vary widely between pharmacies, and essentially no one has marketed the category or explained it.
We're not inventing it. We're just going to stop whispering about it — treating it like the medical option it always was, with compounding pharmacies, customized formulas, and clinicians who explain the risks.
Compounded topical preparations for female sexual arousal disorder are prepared by licensed compounding pharmacies under Section 503A and prescribed off-label. They are not FDA approved, formulations differ between pharmacies, and the evidence base varies by ingredient. See the scoping review in The Journal of Sexual Medicine.
There is no mass-manufactured product for this, because the FDA has never approved one. So yours is made individually — a licensed compounding pharmacy prepares it against a prescription written for you, at a strength your clinician chooses.
A non-hormonal cream applied locally to increase blood flow to genital tissue. Prepared for you individually. Used as needed, not daily. Your clinician reviews the compound, dosing, and full risk profile with you.
What “compounded” means, plainly: a state-licensed pharmacy prepares your medication to order against a prescription written specifically for you, rather than dispensing a mass-manufactured product. It is the standard route for conditions with no approved drug, and there is no FDA-approved treatment indicated for female sexual arousal disorder. Compounded medications are not FDA approved, and the FDA has not evaluated this formulation for safety, effectiveness, or quality.
A private online questionnaire covering your symptoms, health history, and current medications. About six minutes. No video call required.
A licensed clinician reviews your intake and determines whether treatment is appropriate — or tells you honestly if it isn't, and what else to consider.
An unmarked box with no branding and no product name on the label. Refills monthly, with ongoing clinician messaging included.
Health information is sensitive, and this category more than most. Every touchpoint is built for privacy.
Founding members get first access to clinician review, the founding rate, and a say in what we build next. Launching this fall.